Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Smith & Nephew Plc    SN.   GB0009223206

SMITH & NEPHEW PLC

(SN.)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
10/20/2020 10/21/2020 10/22/2020 10/23/2020 10/26/2020 Date
1486(c) 1439.5(c) 1456(c) 1456.5(c) 1446 Last
921 144 1 550 811 1 304 892 794 287 362 384 Volume
-0.30% -3.13% +1.15% +0.03% -0.72% Change
More quotes
Financials (USD)
Sales 2020 4 687 M - -
Net income 2020 401 M - -
Net Debt 2020 1 646 M - -
P/E ratio 2020 42,9x
Yield 2020 1,53%
Sales 2021 5 330 M - -
Net income 2021 710 M - -
Net Debt 2021 1 317 M - -
P/E ratio 2021 23,1x
Yield 2021 2,06%
Capitalization 16 600 M 16 608 M -
EV / Sales 2020 3,89x
EV / Sales 2021 3,36x
Nbr of Employees 17 500
Free-Float 98,7%
More Financials
Company
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipments. Net sales break down by activity sector as follows: - specialized surgery (73.1%): orthopedics (primarily orthopedic implants ; hips, knees and shoulders) and endoscopy (surgery and damaged tissue repair products, visualization products, etc.); - wound care (26.9%): skin grafts for major burns victims,... 
More about the company
Notations Surperformance© of Smith & Nephew Plc
Trading Rating : Investor Rating :
More Ratings
All news about SMITH & NEPHEW PLC
04:25aWPP appoints former Baidu executive Ya-Qin Zhang to board
RE
10/22MISSING APPOINTMENTS : Supreme Court Grants Certiorari In Arthrex V. Smith & Nep..
AQ
10/21SMITH & NEPHEW : +Nephew announces remote Physical Therapy functionality, expand..
AQ
10/21SMITH & NEPHEW : Katarzyna Mazur-Hofsaess joins Smith+Nephew's Board as Non-Exec..
AQ
10/20SMITH & NEPHEW : Katarzyna Mazur-Hofsaess joins Smith+Nephew's Board as Non-Exec..
PU
10/15SMITH & NEPHEW PLC : Dividends
CO
10/13U.S. Supreme Court to hear challenge to influential patent court
RE
10/13SMITH & NEPHEW : U.S. Supreme Court to hear challenge to influential patent cour..
RE
10/12SMITH & NEPHEW : Timing of Smith+Nephew Third Quarter 2020 Trading Report
AQ
10/09SMITH & NEPHEW : Timing of Smith+Nephew Third Quarter 2020 Trading Report
PU
10/065 Long Term Incentive Plans Overwhelmingly Voted By Investors
AQ
10/02SMITH & NEPHEW : +Nephew update on third quarter trading
AQ
10/01SMITH & NEPHEW : +Nephew update on third quarter trading
PU
10/01SMITH & NEPHEW : revenue slide to slow in third quarter
RE
10/01SMITH & NEPHEW : Expects 3Q Underlying Revenue to Fall 4%
DJ
More news
News in other languages on SMITH & NEPHEW PLC
04/30SMITH & NEPHEW PLC : Veröffentlichung des Quartalsumsatzes
04/30SMITH & NEPHEW PLC : publication du chiffre d'affaires trimestriel
02/20SMITH & NEPHEW PLC : prudent vis-à-vis du coronavirus
02/20Les investisseurs renouent avec la prudence face au coronavirus
01/23SMITH & NEPHEW : Eine neu veröffentlichte multizentrische RCT zeigt, dass Smith+..
More news
Analyst Recommendations on SMITH & NEPHEW PLC
More recommendations
Chart SMITH & NEPHEW PLC
Duration : Period :
Smith & Nephew Plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SMITH & NEPHEW PLC
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 15
Average target price 23,15 $
Last Close Price 18,99 $
Spread / Highest target 48,5%
Spread / Average Target 21,9%
Spread / Lowest Target 0,54%
EPS Revisions
Managers
NameTitle
Roland D. Diggelmann Chief Executive Officer & Non-Executive Director
Roberto Quarta Chairman
Mark Gladwell President-Global Operations & Business Services
Anne-Francoise Nesmes Chief Financial Officer & Executive Director
Vasant Padmanabhan President-Research & Development
Sector and Competitors